Psoriatic Arthritis
Latest News
Study Finds Mace Risk Remains High in Patients with Psoriasis, Dyslipidemia
Current guidelines recommend statins “for patients with psoriasis who have additional risk-enhancing factors, similar to recommendations made for...
From the Journals
Cortisol Test Confirms HPA Axis Recovery from Steroid Use
A test that measures serum cortisol levels to predict recovery of the hypothalamic-pituitary-adrenal axis in patients tapering down chronic...
Latest News
Recent Evidence for Home Phototherapy Benefits May Improve Access for Patients with Psoriasis
"It's important for physicians, insurance companies, and patients with psoriasis to understand that this is a very safe and effective form of...
Opinion
Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
Legislative or regulatory action is unlikely to address the current negative reimbursement situation for office-based infusion of certain...
Latest News
Combined Pediatric Derm-Rheum Clinics Supported by Survey Respondents
Perceived benefits of combined clinics were improved patient care through coordinated treatment decisions and timely communication between...
News from the FDA/CDC
Second Ustekinumab Biosimilar Gets FDA Approval
The biosimilar is expected to be marketed in the United States on or after February 21, 2025.
From the Journals
Worldwide Prevalence of Psoriatic Arthritis More Precisely Determined
Psoriatic arthritis (PsA) is more prevalent in Europe and North America than in Asia and South America, according to a meta-analysis that assessed...
Make the Diagnosis
A 30-Year-Old White Female Presented With a 4-Month History of Scaly, Erythematous Patches and Plaques on Her Trunk and Extremities
The patient's medical history was significant for Crohn's disease, and her medications included methotrexate and intravenous infliximab.
Latest News
Europe’s Quest for Earlier Diagnosis of Psoriatic Arthritis
European research consortium aims to set forth improved guidelines on PSA biomarkers, diagnostic and monitoring tools, and more.
Latest News
Approval of Spesolimab for Generalized Pustular Psoriasis Expanded
Spesolimab is an injectable antibody that blocks the IL-36 receptor, a key part of the pathway shown to be involved in the cause of GPP.
Latest News
LITE Study Provides Encouraging Data on Home-Based Phototherapy for Psoriasis
Office-based phototherapy is not available in 90% of counties in the United States, “and a lack of US data has resulted in many insurance...